GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas.
The Kentucky company has continued its return from bankruptcy by acquiring CBD Capital, a provider of CBD distillate, isolate and water-soluble bulk ingredients as well as white and private label services to the UK, the EU and markets worldwide.
It follows the earlier acquisition of UK-based Taylor Mammon, another major player in the same field.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.